The Melbourne healthtech’s oversubscribed Series A, led by Airtree, funds a move into the UK and a pitch to coordinate a patient’s health data over a lifetime rather than a single appointment.
Most healthcare systems are built to wait. They are organised around the moment something goes wrong, the appointment booked because a symptom appeared, with the records, the specialists and the follow-up scattered across providers that rarely talk to one another.
Everlab, a Melbourne healthtech founded in 2023, has raised AU$65m to bet on the opposite premise: that the more valuable system is the one that notices the problem before the patient does.
The Series A, which the company says was oversubscribed, was led by Australia’s Airtree Ventures, with participation from Europe’s Plural and existing backers Left Lane Capital in the US and b2venture in Europe.
The 💜 of EU techThe latest rumblings from the EU tech scene, a story from our wise ol' founder Boris, and some questionable AI art. It's free, every week, in your inbox. Sign up now!Among the angel investors is the Australian Test cricket captain Pat Cummins. It is a substantial step up from the company’s US$10m seed round, raised less than a year earlier in July 2025.
